U.S. Markets closed

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
506.48+2.06 (+0.41%)
At close: 4:00PM EDT

506.48 0.00 (0.00%)
After hours: 7:55PM EDT

Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 0.19
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3664.64
52 Week Low 3441.00
50-Day Moving Average 3469.21
200-Day Moving Average 3517.08

Share Statistics

Avg Vol (3 month) 31.05M
Avg Vol (10 day) 3728.1k
Shares Outstanding 5104.86M
Implied Shares Outstanding 6N/A
Float 99.29M
% Held by Insiders 13.00%
% Held by Institutions 191.03%
Shares Short (Mar 30, 2021) 42.21M
Short Ratio (Mar 30, 2021) 42.36
Short % of Float (Mar 30, 2021) 42.85%
Short % of Shares Outstanding (Mar 30, 2021) 42.06%
Shares Short (prior month Feb 25, 2021) 42.32M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020


Profit Margin 42.28%
Operating Margin (ttm)39.65%

Management Effectiveness

Return on Assets (ttm)12.88%
Return on Equity (ttm)31.77%

Income Statement

Revenue (ttm)8.31B
Revenue Per Share (ttm)77.23
Quarterly Revenue Growth (yoy)20.00%
Gross Profit (ttm)4.46B
Net Income Avi to Common (ttm)3.51B
Diluted EPS (ttm)30.52
Quarterly Earnings Growth (yoy)45.10%

Balance Sheet

Total Cash (mrq)3.59B
Total Cash Per Share (mrq)34.44
Total Debt (mrq)2.71B
Total Debt/Equity (mrq)24.56
Current Ratio (mrq)3.62
Book Value Per Share (mrq)106.05

Cash Flow Statement

Operating Cash Flow (ttm)2.62B
Levered Free Cash Flow (ttm)948.45M